Loading...

FITC anti-human CD105 Antibody

Pricing & Availability
Clone
43A3 (See other available formats)
Regulatory Status
RUO
Other Names
Endoglin
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
43A3_FITC_050707
Human monocytic cell line THP-1 stained with 43A3 FITC
  • 43A3_FITC_050707
    Human monocytic cell line THP-1 stained with 43A3 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
323203 25 tests 72€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
323204 100 tests 137€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD105 is also known as Endoglin. It is a type I integral membrane homodimer protein with subunits of 90 kD found on vascular endothelial cells and syncytiotrophoblasts of placenta. CD105 is weakly expressed on stromal fibroblasts. It is also expressed on activated monocytes and tissue macrophages. Expression of CD105 is increased on activated endothelium in tissues undergoing angiogenesis, such as in tumors, or in cases of wound healing or dermal inflammation. CD105 is a component of the TGF-β receptor system in human umbilical vein endothelial cells and binds TGF-β1 and β3 with high affinity but does not bind to TGF-β2.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
L-cells transfected with human CD105
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Application References

(PubMed link indicates BioLegend citation)
  1. Bühring HJ, et al. 1991. Leukemia 5:841.
  2. Vogel W, et al. 2002. Haematologica 88:126.
  3. Osaka M, et al. 2011. Brain Res. 9:1343. PubMed
  4. HonMou O, et al. 2011. Brain. 134:1790. PubMed
  5. Herrera MB, et al. 2013. Hepatology. 57:311. PubMed
  6. Iohara K, et al. 2014. Exp Gerontol. 52:39. PubMed
Product Citations
  1. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  2. Zhang T, et al. 2022. IUBMB Life. 74:1081. PubMed
  3. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  4. Fu H, et al. 2023. Regen Ther. 22:7. PubMed
  5. Nushtaeva A, et al. 2023. Int J Mol Sci. 24: . PubMed
  6. Xin Y, et al. 2021. Stem Cell Res Ther. 49:12. PubMed
  7. Okochi M, et al. 2008. Biochem Biophys Res Commun. 371:85. PubMed
  8. Ishizaka R, et al. 2012. Biomaterials. 33:2109. PubMed
  9. Vishnoi M, et al. 2018. Cancer Res. 78:5349. PubMed
  10. Han X, et al. 2020. Int J Oral Sci. 12:10. PubMed
  11. Jin J, et al. 2014. J Biosci Bioeng. 118:593. PubMed
  12. Kerr BA, et al. 2021. Experimental Cell Research. 399(2):112456. PubMed
  13. Uezumi A, al < 2014. Cell Death Dis. 5:1186. PubMed
  14. Zhang X, et al. 2010. Exp Biol Med. 235:1505. PubMed
  15. Oeztuerk-Winder F, et al. 2012. EMBO J. 31:3431. PubMed
  16. Fiedorowicz M, et al. 2020. Sci Rep. 10:5379. PubMed
  17. Nodomi S, et al. 2016. Oncogene. 10.1038/onc.2016.72. PubMed
  18. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  19. Keshtkar S, et al. 2021. Stem Cells Int. 8857457:2020. PubMed
  20. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  21. Khan M, et al. 2016. PLoS One. 11:e0165718. PubMed
  22. Motedayyen H, et al. 2017. BMC Res Notes. . 10.1186/s13104-017-2880-6. PubMed
  23. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  24. Aomatsu E, et al. 2014. Sci Rep. 4:3652. PubMed
  25. Xing D, et al. 2020. Cell Transplant. 29:963689720932142. PubMed
  26. He Z, et al. 2020. J Exp Clin Cancer Res. 39:140. PubMed
  27. Grisendi G, et al. 2010. Cytotherapy. 12:466. PubMed
  28. Liu Y, et al. 2018. Chin J Cancer. 37:2. PubMed
  29. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  30. Vishnoi M, et al. 2019. Mol Oncol. 13(9): 1913. PubMed
  31. Hu J, et al. 2022. Stem Cell Res Ther. 13:349. PubMed
  32. Safi R, et al. 2021. Photodermatol Photoimmunol Photomed. 37:202. PubMed
  33. Sprouse ML, et al. 2019. Int J Mol Sci. 20:8. PubMed
  34. Liu Z, et al. 2018. Cancer Med. 10.1002/cam4.1584. PubMed
RRID
AB_755956 (BioLegend Cat. No. 323203)
AB_755956 (BioLegend Cat. No. 323204)

Antigen Details

Structure
Associates with TGF-ß receptor I and II, homodimeric type I integral membrane protein, 90 kD
Distribution

Endothelial cells, activated monocytes/macrophages, bone marrow stromal cells, hematopoietic stem/progenitor cells

Function
Modulates cellular response to TGF-ß, involved in vascular development and remodelling
Ligand/Receptor
TGF-ß1, TGF-ß3
Cell Type
Endothelial cells, Hematopoietic stem and progenitors, Macrophages, Mesenchymal Stem Cells, Monocytes
Biology Area
Angiogenesis, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Mason D, et al. Eds. 2002. Leucocyte Typing VII. Oxford University Press. New York.
2. Pierelli L, et al. 2001. Leuk. Lymphoma 42:1195.

Gene ID
2022 View all products for this Gene ID
UniProt
View information about CD105 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account